Collaborative Partnership to Support Full-Cycle Bio Healthcare New Drug Development
[Medical Newspaper · Ilgan Bosa] The Korea Drug Development Research Association (KDRA) announced on the 23rd that it signed a Memorandum of Understanding for full-cycle bio healthcare new drug development support with Dream CIS, MediTip, and BXPLANT at KDRA’s main conference room to advance Korea’s bio healthcare industry.
The signing ceremony was attended by KDRA Standing Director Jae-cheon Yeo and Division Head Heon-je Cho, Dream CIS and MediTip CEO Jung-hee Yoo, BXPLANT Co-CEOs Minkeun Jo and Heesun Kim, along with representatives from each organization.
Key Provisions of the Agreement
The main objectives of this MOU include:
- Joint support for full-cycle strategic consulting services across specialized areas including early-stage R&D, preclinical trials, regulatory affairs, clinical trials, business development, and investment for KDRA member companies as well as domestic pharmaceutical and bio companies
- Joint development of strategic training programs in each domain—early-stage R&D, preclinical/clinical development, regulatory affairs, and business development—to support global market entry
KDRA R&D Promotion Division Head Heon-je Cho stated, “Through this agreement, KDRA will work in close cooperation with Dream CIS, MediTip, and BXPLANT to establish a comprehensive support environment for full-cycle bio healthcare new drug development strategies, enabling domestic companies to build global competitiveness.”
About the Partner Organizations
Dream CIS is a global CRO providing services across all domains related to research and development in the pharmaceutical, bio, and medical device industries. MediTip, a subsidiary of Dream CIS, specializes in pharmaceutical and medical device regulatory affairs and strategic consulting—the largest such operation in Korea. BXPLANT is a CDRO company that supports drug development operations across the full cycle of new drug development, from early-stage R&D strategy through preclinical and clinical development to clinical trials.
source : KDRA Signs MOU with DreamCIS, MediTip, and BXPLANT, Jeong-il Kim, Medical Newspaper · Ilgan Bosa, 2024.12.23., http://www.bosa.co.kr/news/articleView.html?idxno=2238806
